3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Down Syndrome
3
Osteosarcoma
2
Lymphoma, Mantle-Cell
2
Urothelial Carcinoma of the Bladder
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Mouth Neoplasms
1
Meningeal Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
GATA2 Deficiency
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma
1
Interventions
empagliflozin
1
Environmental Biomarkers
1
Echocardiography
1
Carvedilol
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Methotrexate
×
30 days
×
Clear all
No trials found.